Among the three components (MHC class I, MHC class II, and complex) of the pathway, MHC I-mediated antigen processing was responsible for enrichment, and it was the initiator of tumor antigen recognition and CD8+ T cell activation [28]. The gene discussed is CD8A; the disease is neoplasm.